Literature DB >> 32726565

A Single-cell Atlas of the Human Healthy Airways.

Marie Deprez1,2, Laure-Emmanuelle Zaragosi1,2, Marin Truchi1,2, Christophe Becavin1,2, Sandra Ruiz García1,2, Marie-Jeanne Arguel1,2, Magali Plaisant1,2, Virginie Magnone1,2, Kevin Lebrigand2, Sophie Abelanet1,2, Frédéric Brau1,2, Agnès Paquet1,3, Dana Pe'er4, Charles-Hugo Marquette5,6,7,8, Sylvie Leroy5,2,9, Pascal Barbry1,10.   

Abstract

Rationale: The respiratory tract constitutes an elaborated line of defense that is based on a unique cellular ecosystem. Single-cell profiling methods enable the investigation of cell population distributions and transcriptional changes along the airways.
Methods: We have explored the cellular heterogeneity of the human airway epithelium in 10 healthy living volunteers by single-cell RNA profiling. 77,969 cells were collected at 35 distinct locations, from the nose to the 12th division of the airway tree.
Results: The resulting atlas is composed of a high percentage of epithelial cells (89.1%), but also immune (6.2%) and stromal (4.7%) cells with distinct cellular proportions in different regions of the airways. It reveals differential gene expression between identical cell types (suprabasal, secretory, and multiciliated cells) from the nose (MUC4, PI3, SIX3) and tracheobronchial (SCGB1A1, TFF3) airways. By contrast, cell-type specific gene expression is stable across all tracheobronchial samples. Our atlas improves the description of ionocytes, pulmonary neuro-endocrine (PNEC) and brush cells, and identifies a related population of NREP-positive cells. We also report the association of KRT13 with dividing cells that are reminiscent of previously described mouse "hillock" cells, and with squamous cells expressing SCEL, SPRR1A/B. Conclusions: Robust characterization of a single-cell cohort in healthy airways establishes a valuable resource for future investigations. The precise description of the continuum existing from the nasal epithelium to successive divisions of the airways and the stable gene expression profile of these regions better defines conditions under which relevant tracheobronchial proxies of human respiratory diseases can be developed.

Entities:  

Keywords:  Single-cell RNAseq; biopsies; bronchoscopy; brushings; data integration

Year:  2020        PMID: 32726565     DOI: 10.1164/rccm.201911-2199OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  63 in total

1.  Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19.

Authors:  Ji Hoon Ahn; JungMo Kim; Seon Pyo Hong; Sung Yong Choi; Myung Jin Yang; Young Seok Ju; Young Tae Kim; Ho Min Kim; M D Tazikur Rahman; Man Ki Chung; Sang Duk Hong; Hosung Bae; Chang-Seop Lee; Gou Young Koh
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

2.  National Heart, Lung, and Blood Institute and Building Respiratory Epithelium and Tissue for Health (BREATH) Consortium Workshop Report: Moving Forward in Lung Regeneration.

Authors:  Robert E Hynds; William J Zacharias; Marko Z Nikolić; Melanie Königshoff; Oliver Eickelberg; Reinoud Gosens; Paolo de Coppi; Sam M Janes; Edward Morrisey; Hans Clevers; Amy L Ryan; Barry R Stripp; Xin Sun; Carla F Kim; Qing S Lin
Journal:  Am J Respir Cell Mol Biol       Date:  2021-07       Impact factor: 6.914

3.  A molecular single-cell lung atlas of lethal COVID-19.

Authors:  Johannes C Melms; Jana Biermann; Huachao Huang; Yiping Wang; Ajay Nair; Somnath Tagore; Igor Katsyv; André F Rendeiro; Amit Dipak Amin; Denis Schapiro; Chris J Frangieh; Adrienne M Luoma; Aveline Filliol; Yinshan Fang; Hiranmayi Ravichandran; Mariano G Clausi; George A Alba; Meri Rogava; Sean W Chen; Patricia Ho; Daniel T Montoro; Adam E Kornberg; Arnold S Han; Mathieu F Bakhoum; Niroshana Anandasabapathy; Mayte Suárez-Fariñas; Samuel F Bakhoum; Yaron Bram; Alain Borczuk; Xinzheng V Guo; Jay H Lefkowitch; Charles Marboe; Stephen M Lagana; Armando Del Portillo; Emily J Tsai; Emmanuel Zorn; Glen S Markowitz; Robert F Schwabe; Robert E Schwartz; Olivier Elemento; Anjali Saqi; Hanina Hibshoosh; Jianwen Que; Benjamin Izar
Journal:  Nature       Date:  2021-04-29       Impact factor: 49.962

Review 4.  Implications for Extracellular Matrix Interactions With Human Lung Basal Stem Cells in Lung Development, Disease, and Airway Modeling.

Authors:  Shana M Busch; Zareeb Lorenzana; Amy L Ryan
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

5.  Early-life viral infections are associated with disadvantageous immune and microbiota profiles and recurrent respiratory infections.

Authors:  Rebecca L Watson; Emma M de Koff; Wouter A A de Steenhuijsen Piters; Raiza Hasrat; Kayleigh Arp; Mei Ling J N Chu; Pieter C M de Groot; Marlies A van Houten; Elisabeth A M Sanders; Debby Bogaert
Journal:  Nat Microbiol       Date:  2022-01-20       Impact factor: 17.745

6.  Update in Pediatrics 2020.

Authors:  Erick Forno; Steven H Abman; Jagdev Singh; Mary E Robbins; Hiran Selvadurai; Paul T Schumacker; Paul D Robinson
Journal:  Am J Respir Crit Care Med       Date:  2021-08-01       Impact factor: 30.528

Review 7.  Human Molecular Genetics and the long road to treating cystic fibrosis.

Authors:  Ann Harris
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 5.121

8.  Multi-resolution characterization of molecular taxonomies in bulk and single-cell transcriptomics data.

Authors:  Eric R Reed; Stefano Monti
Journal:  Nucleic Acids Res       Date:  2021-09-27       Impact factor: 16.971

Review 9.  State of the art on lung organoids in mammals.

Authors:  Fabienne Archer; Alexandra Bobet-Erny; Maryline Gomes
Journal:  Vet Res       Date:  2021-06-02       Impact factor: 3.683

10.  Remodeling of bronchial epithelium caused by asthmatic inflammation affects its response to rhinovirus infection.

Authors:  Bogdan Jakiela; Ana Rebane; Jerzy Soja; Stanislawa Bazan-Socha; Anet Laanesoo; Hanna Plutecka; Marcin Surmiak; Marek Sanak; Krzysztof Sladek; Grazyna Bochenek
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.